Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd. is a leading Indian multinational pharmaceutical company with over a century of history. It specializes in the manufacture of generic pharmaceuticals and active pharmaceutical ingredients. The company has over 350 marketed drugs worldwide and more than sixty clinical trials ongoing or completed. Its US business accounts for nearly one-third of revenue with an expanding pipeline focused on complex generics including injectables and specialty products such as oncology and ophthalmology drugs. Recent approvals include brexpiprazole tablets for major depressive disorder and ivabradine hydrochloride for chronic heart failure.[1][4][6][9]